Page last updated: 2024-08-21

angelicin and Kidney Neoplasms

angelicin has been researched along with Kidney Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, YH; Kim, S; Kim, SH; Kwon, TK; Lee, HS; Lee, TJ; Min, KJ; Park, JW; Seo, SU; Um, HJ; Woo, SM	1

Other Studies

1 other study(ies) available for angelicin and Kidney Neoplasms

Article	Year
Angelicin potentiates TRAIL-induced apoptosis in renal carcinoma Caki cells through activation of caspase 3 and down-regulation of c-FLIP expression. Drug development research, 2018, Volume: 79, Issue:1 Topics: Apoptosis; Carcinoma, Renal Cell; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Cell Line, Tumor; Cells, Cultured; DNA Fragmentation; Down-Regulation; Drug Synergism; Fibroblasts; Furocoumarins; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; TNF-Related Apoptosis-Inducing Ligand	2018

Article

Year

Angelicin potentiates TRAIL-induced apoptosis in renal carcinoma Caki cells through activation of caspase 3 and down-regulation of c-FLIP expression.

Drug development research, 2018, Volume: 79, Issue:1

Topics: Apoptosis; Carcinoma, Renal Cell; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Cell Line, Tumor; Cells, Cultured; DNA Fragmentation; Down-Regulation; Drug Synergism; Fibroblasts; Furocoumarins; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; TNF-Related Apoptosis-Inducing Ligand

2018